iBio Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Details Textual)

Stockholders' Equity (Details Textual) - USD ($)		1 Months Ended					3 Months Ended	12 Months Ended
Stockholders' Equity (Details Textual) - USD ($)	May. 15, 2015	Apr. 28, 2015	Sep. 19, 2014	Aug. 25, 2014	Nov. 30, 2013	Oct. 31, 2013	Sep. 30, 2015	Jun. 30, 2015	Jun. 30, 2014	Sep. 26, 2014	Dec. 18, 2013	Oct. 15, 2013	Jun. 30, 2013
Stockholders' Equity [Line Items]
Preferred Stock, Shares Authorized								1,000,000	1,000,000
Common Stock, Shares Authorized								175,000,000	175,000,000				100,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized								15,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period								26,691
Proceeds from Issuance of Common Stock								$ 10,000,000	$ 480,000
Stock Issued During Period, Value, New Issues								10,000,000	3,100,000
Payments of Stock Issuance Costs								$ 0	$ 29,000
Class of Warrant or Right, Exercise Price of Warrants or Rights								$ 1.63	$ 1.38				$ 1.23
November 2013 Private Placement Offering [Member]
Stockholders' Equity [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period					1,200,000
Proceeds from Issuance of Common Stock					$ 500,000
Share Price					$ 0.40
Warrant [Member]
Stockholders' Equity [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period						7,750,000		75,000
Proceeds from Issuance of Common Stock						$ 3,100,000
Exercise Price of Warrants, Reduced												$ 0.40
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 0.88
Investments Warrants Expiration Date						Jan. 14, 2014
Reduced Warrants Expiration Date Description					5:00 p.m. on November 12, 2013 (the Expiration Time),
Common Stock [Member]
Stockholders' Equity [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized											175,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period								6,600,000
Stock Issued During Period, Shares, New Issues								8,769,000	7,750,000
Stock Issued During Period, Value, New Issues								$ 9,000	$ 8,000
Stock Issued During Period, Shares, Other									1,200,000
Aspirre Purchase Agreement 2015 [Member]
Stockholders' Equity [Line Items]
Percentage Of Aggregate Shares Of Company	35.00%
Percentage Of Closing Price Of Common Stock	80.00%
Percentage Of Volume Weighted Average Price	97.00%
Stock Issued During Period, Shares, Other	150,000
Share Price	$ 0.40
Aspirre Purchase Agreement 2015 [Member] \| Subsequent Event [Member]
Stockholders' Equity [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period							120,000
Proceeds from Issuance of Common Stock							$ 64,000
Aspire Capital Fund, LLC 2014 [Member]
Stockholders' Equity [Line Items]
Aggregate Common Stock Purchased				$ 10,000,000				10,000,000
Proceeds from Issuance of Common Stock		$ 10,000,000						$ 10,000,000
Floor Price Of Common Stock										$ 0.20
Stock Issued During Period, Shares, New Issues			1,136,354	681,818				8,768,806
Stock Issued During Period, Value, New Issues			$ 10,000,000					$ 500,000	$ 10,000,000
Percentage Of Commitment Fee On Total Proceeds								3.00%
Payments of Stock Issuance Costs								$ 300,000
Sale of Stock, Number of Shares Issued in Transaction								0.44
Percentage Of Aggregate Shares Of Company								30.00%
Percentage Of Closing Price Of Common Stock								80.00%
Percentage Of Volume Weighted Average Price								97.00%
Stock Issued During Period, Shares, Other								150,000
Share Price								$ 0.44
Shares Issued, Price Per Share			$ 0.44
Aspire Capital Fund, LLC 2014 [Member] \| Registration Rights Agreement [Member]
Stockholders' Equity [Line Items]
Sale of Stock, Price Per Share				$ 0.44
Aspire Capital Fund, LLC 2015 [Member]
Stockholders' Equity [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period								1,636,000
Proceeds from Issuance of Common Stock								$ 867,000
Sale of Stock, Number of Shares Issued in Transaction	450,000
Percentage Of Common Stock Outstanding								19.99%
Commitment Shares Issued During Period								450,000
Maximum Amount Available For Purchase Of Shares								$ 15,000,000
Aspire Capital Fund, LLC 2015 [Member] \| Aspirre Purchase Agreement 2015 [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Shares, Other								15,343,406